Skip to content

Perspective Therapeutics Inc

CATX

Latest QuantConomy context for CATX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
NYSE MKT
Recent signals
3
SEC filings
10
Asset profile

Perspective Therapeutics Inc

QuantConomy has a structured record for CATX. More descriptive asset metadata will appear here when the platform record includes it.

Symbol
CATX
Name
Perspective Therapeutics Inc
Coverage
3 market/data records
Sources
alphavantage fmp alpaca sec nasdaq openfigi
Latest signal rows

Recent signals for CATX

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
eps change
very bullish
76
Jul 11, 12:00 AM CATX (Q1 2026, diluted eps): EPS grew 82.1% ($-1.40 → $-0.25). [sequential period basis, very bullish signal]
net income change
very bullish
76
Jul 11, 12:00 AM CATX (Q1 2026, net income): grew 74.6% (-$103.12M → -$26.19M). [sequential period basis, very bullish signal]
operating income change
very bullish
76
Jul 11, 12:00 AM CATX (Q1 2026, operating income): grew 75.1% (-$113.56M → -$28.28M). [sequential period basis, very bullish signal]

FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.

Market coverage

Market Exchange Source Asset record
CATX NYSE MKT alphavantage Perspective Therapeutics Inc
CATX AMEX fmp Perspective Therapeutics, Inc.
CATX AMEX alpaca Perspective Therapeutics, Inc.

Recent insider transactions

Buys, last 90d
0
Sells, last 90d
0
Rows
10
Date Insider Role Type Shares Price Value Filing
Mar 2, 2026 Puhlmann Markus Chief Medical Officer grant 150,000 4 on EDGAR
Mar 2, 2026 Woods Lori A Director grant 50,000 4 on EDGAR
Mar 2, 2026 HENSON HEIDI Director grant 50,000 4 on EDGAR
Mar 2, 2026 Spoor Johan M. Chief Executive Officer grant 735,000 4 on EDGAR
Mar 2, 2026 Martinez Maria E Director grant 50,000 4 on EDGAR
Mar 2, 2026 Morich Frank Director grant 50,000 4 on EDGAR
Mar 2, 2026 Williamson Robert F III Director grant 50,000 4 on EDGAR
Mar 2, 2026 Hunt Jonathan Robert Chief Accounting Officer grant 90,000 4 on EDGAR
Nov 13, 2025 Hunt Jonathan Robert Chief Accounting Officer purchase 11,000 $2.03 $22,295 4 on EDGAR
Nov 12, 2025 Williamson Robert F III Insider purchase 9,498 $2.10 $19,946 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query CATX context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access